O
DGX icon

OppenheimerFunds’s Quest Diagnostics DGX Stock Holding History

OppenheimerFunds’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$10.9M Sell
120,801
-9,450
-7% -$819K 0.01% 657
2018
Q4 		$10.8M Sell
130,251
-354,506
-73% -$33.2M 0.02% 652
2018
Q3 		$52.3M Sell
484,757
-217,032
-31% -$23.8M 0.06% 320
2018
Q2 		$77.2M Sell
701,789
-568
-0.1% -$59.2K 0.09% 243
2018
Q1 		$70.4M Sell
702,357
-5,415
-0.8% -$555K 0.09% 249
2017
Q4 		$69.7M Buy
707,772
+14,674
+2% +$1.39M 0.08% 244
2017
Q3 		$64.9M Buy
693,098
+159,288
+30% +$16.9M 0.08% 266
2017
Q2 		$59.3M Buy
533,810
+1,641
+0.3% +$174K 0.07% 266
2017
Q1 		$52.3M Sell
532,169
-61,584
-10% -$5.87M 0.06% 291
2016
Q4 		$54.6M Buy
593,753
+2,708
+0.5% +$233K 0.07% 292
2016
Q3 		$50M Buy
591,045
+582,170
+6,560% +$48.9M 0.06% 323
2016
Q2 		$723K Sell
8,875
-404
-4% -$30.8K ﹤0.01% 1110
2016
Q1 		$668K Sell
9,279
-277
-3% -$18.6K ﹤0.01% 1127
2015
Q4 		$683K Buy
+9,556
New +$642K ﹤0.01% 1171
2013
Q4 		– Sell
-209,501
Closed -$12.9M – 913
2013
Q3 		$12.9M Buy
209,501
+12,930
+7% +$774K 0.02% 656
2013
Q2 		$11.9M Buy
+196,571
New +$11.7M 0.02% 646

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds's DGX Position: Q1 2019 in Review

OppenheimerFunds reduced its Quest Diagnostics (DGX) stake by 7.3% in Q1 2019, selling an estimated $819K and leaving 120,801 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #657.

OppenheimerFunds first reported a position in DGX in Q2 2013 and has held it in 16 quarters since. The position peaked at $77.2M in Q2 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • OppenheimerFunds held 120,801 shares of Quest Diagnostics worth $10.9M as of Q1 2019.
  • OppenheimerFunds sold 9,450 Quest Diagnostics shares in Q1 2019, an estimated $819K.
  • Quest Diagnostics made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #657 holding.
  • OppenheimerFunds first reported a position in Quest Diagnostics in Q2 2013 and has held it in 16 quarters since.
  • OppenheimerFunds's Quest Diagnostics position peaked at $77.2M in Q2 2018.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.